Scientists analyzed a group of 438 participants with a history of uveitis who received at least one dose of the COVID-19 vaccine but had no history of previous COVID-19 infection. Participants received one of the vaccines available in China, including Sinovac, Sinopharm, CanSino, and Zhifei.
Read More »Behçet’s disease patients are usually on long-term therapy with colchicine, TNF inhibitors, or glucocorticoids; a recent study aimed to understand the prevalence of COVID-19-related clinical outcomes in Behçet’s disease patients treated with these therapies.
Read More »A recent study investigated COVID-19 outcomes in patients with primary and secondary immunodeficiency, comparing hospitalization rates and mortality between both vaccinated and unvaccinated patients.
Read More »Those suffering from systemic autoimmune rheumatic diseases have an increased risk of severe outcomes from a COVID-19 infection. Due to factors such as altered immunity or the use of immunosuppressive medications, they may also be at risk of developing Long COVID.
Read More »